A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib
Kumamoto, Tadashi, Aoki, Yuki, Sonoda, Tomoko, Yamanishi, Miho, Arakawa, Ayumu, Sugiyama, Masanaka, Shirakawa, Nami, Ishimaru, Sae, Saito, Yoshimasa, Maeshima, Akiko, Maeda, Miho, Ogawa, ChitoseLangue:
english
Journal:
International Journal of Hematology
DOI:
10.1007/S12185-018-2553-9
Date:
October, 2018
Fichier:
PDF, 1.38 MB
english, 2018
File converter
Plus de résultats de recherche
More benefits 
